Britain’s National Health Service (NHS) will reportedly begin offering coronavirus patients the same antibody treatment that President Donald Trump received when he contracted the Chinese virus last year.
A cocktail of antibody drugs developed by the American biotechnology company Regeneron Pharmaceuticals is set to be offered to those who test positive for COVID-19 in the UK in the hopes of preventing the healthcare system from being overrun by hospitalisations.
The coronavirus treatment was given fast-tracked approval in the United States following claims from then-President Trump claimed that the therapy represented a “cure” to the Wuhan virus.
The Chief Executive Officer of the NHS, Sir Simon Stevens has instructed the UK’s health service to begin preparations to deliver the Regeneron treatment, according to Britain’s Daily Telegraph.
“We expect that we will begin to see further therapies that will actually treat coronavirus and prevent severe illness and death,” Sir Simon told an NHS Confederation virtual conference on Tuesday.